Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2001, p. 3256-3265, Vol. 21, No. 9
Department of Oncology-Pathology, Cellular
and Molecular Tumorpathology, Karolinska Institute/Karolinska Hospital,
S-171 76 Stockholm, Sweden,1 and
Department of Molecular Biology, The Scripps Research
Institute, La Jolla, California 920372
Received 18 October 2000/Returned for modification 27 November
2000/Accepted 9 February 2001
The restriction point (R) is defined as the point in G1
after which cells can complete a division cycle without growth factors and divides G1 into two physiologically different intervals
in cycling cells, G1-pm (a postmitotic interval with a
constant length of 3 to 4 h) and G1-ps (a
pre-DNA-synthetic interval with a variable length of 1 to 10 h).
Cyclin E is a G1 regulatory protein whose accumulation has
been suggested to be critical for passage through R. We have studied
cyclin E protein levels in individual cells of asynchronously growing
cell populations, with respect to both passage through R and entry into
S phase. We found that the postmitotic G1 cells that had
not yet reached R were negative for cyclin E accumulation. On the other
hand, cells that had passed R were found to accumulate cyclin E at
variable times (1 to 8 h) after passage through R and 2 to 5 h before entry into S. These kinetic data rule out the hypothesis that
passage through R is dependent on the accumulation of cyclin E but
suggest, instead, the converse, that passage through R is a
prerequisite for cyclin E accumulation. Furthermore, we found that most
of the cyclin E protein is downregulated within 1 to 2 h after
entry into S.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.9.3256-3265.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Accumulation of Cyclin E Is Not a Prerequisite for
Passage through the Restriction Point
*
Corresponding author. Mailing address: Department of
Oncology and Pathology, Karolinska Institute, Karolinska
Sjukhuset, CCK R8:04, 171 76 Stockholm, Sweden. Phone: (46)
851-77-5250. Fax: (46) 832-1047. E-mail:
anders.zetterberg{at}onkpat.ki.se.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|